EQT AB welcomes the closure of the Swedish Financial Supervisory Authority’s inquiry regarding EQT’s information disclosure
Update in EQT AB's Executive Committee
EQT sets target fund size for EQT Infrastructure VI at EUR 20 billion
Karo Intressenter AB announces a public cash offer to the shareholders in Karo Pharma Aktiebolag
EQT Life Sciences leads USD 20 Million Financing Round in FundamentalVR
EQT Future strengthens Mission Board and installs seasoned bench of Impact Advisors
EQT Life Sciences announces its portfolio company NewAmsterdam Pharma going public
EQT Life Sciences announces strategic alliance of its portfolio company iSTAR Medical with AbbVie
United Talent Agency and EQT Private Equity announce strategic partnership
EQT AB (publ) Half-year Report 2022
